Next Generation Sequencing (NGS) Market Size & Forecast By Application (Oncology, Reproductive Health), By Technology (Targeted Sequencing), By Workflow (Data Analysis), By end-use (Academic & Clinical Research), And Trend Analysis, 2014 - 2025

  • ID: 4076511
  • Report
  • 230 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • CLC Bio
  • Genomatix GmbH
  • Ingenuity
  • Macrogen Inc.
  • Perkin Elmer, Inc.
  • MORE
The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025. Increasing coverage of NGS is expected to drive use of precision medicine in oncology from research based setting to clinical cancer setting. Commercial payers are also engaged in reviewing the existing and novel tests in order to establish appropriate medical necessity criteria for their clinical and medical policies.

Moreover, improved understanding of the genetic markers of virulence and resistance provided by next generation sequencing is expected to drive demand of the technology in infectious disease diagnosis.

Further Key Findings from the Report suggest:

Oncology accounted for the dominant share owing to phase-resolved and unambiguous results obtained by using single assay systems, and analysis program.

Targeted resequencing dominated the market owing to its associated benefits such as implementation of the technique such as lower turnaround time and more manageable data sets.

Academic usage of NGS accounted for the largest share with respect to market revenue by end uses and is anticipated to maintain its dominance.

Higher adoption of this technology and platforms in university projects is expected to support the estimated share.

Asia Pacific is estimated to witness the fastest growth over the forecast period owing to expected routing of a considerable portion of whole genome sequencing requirements herein.

Key players operating in the NGS market include Illumina Inc., Agilent Technologies, BGI, Pacific Biosciences, Qiagen, Roche, Thermo Fischer Scientific, and Oxford Nanopore Technologies Ltd.

Endeavors adopted by participants are such as acquisition of Enzymatics by Qiagen acquired solutions in order to enhance the product portfolio with respect to reagents needed in preparatory steps.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • CLC Bio
  • Genomatix GmbH
  • Ingenuity
  • Macrogen Inc.
  • Perkin Elmer, Inc.
  • MORE
1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region Based Segment Share Calculation
1.3 List of Secondary Sources

2 Executive Summary

3 Next Generation Sequencing Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Exponentially decreasing costs for genetic sequencing
3.1.1.2 Development of companion diagnostics and personalized medicine
3.1.1.3 Rise in competition amongst prominent market entities
3.1.1.4 Rising clinical opportunity for NGS technology
3.1.1.5 Introduction of technological advancements in cloud computing and data integration
3.1.1.6 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.1.1.7 Increasing prevalence of cancer
3.1.2 Market Restraint Analysis
3.1.2.1 Lack of computational efficiency for data management
3.1.2.2 Non-value based NGS reimbursement policy and regulation status
3.1.2.3 Challenges associated with NGS implementation
3.2 Penetration & Growth Prospect Mapping for Applications, 2015
3.3 Penetration & Growth Prospect Mapping for Prominent Industry Players, 2015
3.4 Next Generation Sequencing Platform Positioning
3.4.1 Major Sequencing Platforms Compared - Applications
3.4.2 Major Sequencing Platforms Compared - Specifications
3.5 Next Generation Sequencing Platform Penetration Mapping, 2015
3.6 Next Generation Sequencing Company Market Share Analysis, 2015
3.7 Next Generation Sequencing Reimbursement Environment
3.7.1 Gap fill approach for reimbursement of NGS tests
3.7.2 Role of the commercial payers
3.7.2.1 Payer perspectives for developing coverage policy for Next Generation Tumor Sequencing Panels (NGTS)
3.7.3 Role of diagnostic laboratories and pathology centres
3.8 Next Generation Sequencing Regulatory Environment
3.9 Next Generation Sequencing - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.10 Industry Analysis - Porter’s

4 Next Generation Sequencing Market Application Estimates & Trend Analysis
4.1 Next Generation Sequencing Market: Application Movement Analysis
4.2 Oncology
4.2.1 Global oncology market, 2014 - 2025 (USD Million)
4.3 Clinical Investigation
4.3.1 Global clinical investigation market, 2014 - 2025 (USD Million)
4.3.2 Infectious diseases
4.3.2.1 Global infectious diseases market, 2014 - 2025 (USD Million)
4.3.3 Inherited diseases
4.3.3.1 Global inherited diseases market, 2014 - 2025 (USD Million)
4.3.4 Idiopathic diseases
4.3.4.1 Global idiopathic diseases market, 2014 - 2025 (USD Million)
4.3.5 Non-communicable/other diseases
4.3.5.1 Global non-communicable/other diseases market, 2014 - 2025 (USD Million)
4.4 Reproductive Health
4.4.1 Global reproductive health market, 2014 - 2025 (USD Million)
4.4.2 NIPT
4.4.2.1 Global NIPT market, 2014 - 2025 (USD Million)
4.4.3 PGT
4.4.3.1 Global NGS PGT market, 2014 - 2025 (USD Million)
4.4.4 New-born/genetic screening
4.4.4.1 Global newborn/genetic screening market, 2014 - 2025 (USD Million)
4.5 HLA Typing/Immune System Monitoring
4.5.1 Global HLA typing/immune system monitoring market, 2014 - 2025 (USD Million)
4.6 Metagenomics, Epidemiology & Drug Development
4.6.1 Global metagenomics, epidemiology & drug development market, 2014 - 2025 (USD Million)
4.7 Agrigenomics & Forensics
4.7.1 Global agrigenomics & forensics market, 2014 - 2025 (USD Million)
4.8 Consumer Genomics
4.8.1 Global consumer genomics market, 2014 - 2025 (USD Million)

5 Next Generation Sequencing Market Technology Estimates & Trend Analysis
5.1 Next Generation Sequencing Market: Technology Movement Analysis
5.2 Whole Genome Sequencing
5.2.1 Global whole genome sequencing market, 2014 - 2025 (USD Million)
5.3 Whole Exome Sequencing
5.3.1 Global whole exome sequencing market, 2014 - 2025 (USD Million)
5.4 Targeted Sequencing & Resequencing
5.4.1 Global targeted sequencing & resequencing market, 2014 - 2025 (USD Million)
5.4.2 DNA based targeted sequencing & resequencing
5.4.2.1 Global DNA based targeted sequencing & resequencing market, 2014 - 2025 (USD Million)
5.4.3 RNA based targeted sequencing & resequencing
5.4.3.1 Global RNA based targeted sequencing & resequencing market, 2014 - 2025 (USD Million)

6 Next Generation Sequencing Market Workflow Estimates & Trend Analysis
6.1 Next Generation Sequencing Market: Workflow Movement Analysis
6.2 Pre-Sequencing
6.2.1 Global pre-sequencing market, 2014 - 2025 (USD Million)
6.2.2 NGS library preparation kits
6.2.2.1 Global NGS library preparation kits market, 2014 - 2025 (USD Million)
6.2.3 NGS semi-automated library preparation
6.2.3.1 Global NGS semi-automated library preparation market, 2014 - 2025 (USD Million)
6.2.4 NGS automated library preparation
6.2.4.1 Global NGS automated library preparation market, 2014 - 2025 (USD Million)
6.2.5 Clonal amplification
6.2.5.1 Global clonal amplification market, 2014 - 2025 (USD Million)
6.3 Sequencing
6.3.1 Global sequencing market, 2014 - 2025 (USD Million)
6.4 Data Analysis
6.4.1 Global data analysis market, 2014 - 2025 (USD Million)
6.4.2 NGS primary data analysis
6.4.2.1 Global NGS primary data analysis market, 2014 - 2025 (USD Million)
6.4.3 NGS secondary data analysis
6.4.3.1 Global NGS secondary data analysis market, 2014 - 2025 (USD Million)
6.4.4 NGS tertiary data analysis
6.4.4.1 Global NGS tertiary data analysis services market, 2014 - 2025 (USD Million)

7 Next Generation Sequencing Market End-use Estimates & Trend Analysis
7.1 Next Generation Sequencing Market: End-Use Movement Analysis
7.2 Academic Research
7.2.1 Global academic research market, 2014 - 2025 (USD Million)
7.3 Clinical Research
7.3.1 Global clinical research market, 2014 - 2025 (USD Million)
7.4 Hospitals & Clinics
7.4.1 Global hospitals & clinics market2014 - 2025 (USD Million)
7.5 Pharma & Biotech Entities
7.5.1 Global pharma & biotech entities market, 2014 - 2025 (USD Million)
7.6 Other Users
7.6.1 Global other users market, 2014 - 2025 (USD Million)

8 Next Generation Sequencing Market Regional Estimates & Trend Analysis, by Service Type, Sector & Application
8.1 Next Generation Sequencing Market Share By Region, 2015 & 2025
8.2 North America
8.2.1 North America next generation sequencing market, 2014 - 2025 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. next generation sequencing market, 2014 - 2025 (USD Million)
8.2.3 Canada.
8.2.3.1 Canada next generation sequencing market, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Europe next generation sequencing market, 2014 - 2025 (USD Million)
8.3.2 Germany
8.3.2.1 Germany next generation sequencing market, 2014 - 2025 (USD Million)
8.3.3 UK
8.3.3.1 UK next generation sequencing market, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific next generation sequencing market, 2014 - 2025 (USD Million)
8.4.2 Japan
8.4.2.1 Japan next generation sequencing market, 2014 - 2025 (USD Million)
8.4.3 China
8.4.3.1 China next generation sequencing market, 2014 - 2025 (USD Million)
8.5 Latin America
8.5.1 Latin America next generation sequencing market, 2014 - 2025 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil next generation sequencing market, 2014 - 2025 (USD Million)
8.6 Middle East & Africa
8.6.1 Middle East & Africa next generation sequencing market, 2014 - 2025 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa next generation sequencing market, 2014 - 2025 (USD Million)

9 Competitive Landscape
9.1 Strategy framework
9.2 Market participation categorization
9.3 Company Profiles
9.3.1 Illumina, Inc.
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 Roche Sequencing (454 Life Sciences)
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 Agilent Technologies
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 PierianDx
9.3.4.1 Company Overview
9.3.4.1.1 Tute Genomics
9.3.4.1.2 Knome Inc.
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 Genomatix GmbH
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 GATC Biotech Ag
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 Oxford Nanopore Technologies
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 Macrogen Inc.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Thermo Fisher Scientific, Inc.
9.3.9.1 Company Overview
9.3.9.1.1 Life Technologies Corp.
9.3.9.2 Financial Performance
9.3.9.3 Financial Performance
9.3.9.4 Product Benchmarking
9.3.9.5 Strategic Initiatives
9.3.10 DNASTAR Inc.
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 Biomatters Ltd.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Qiagen NV
9.3.12.1 Company Overview
9.3.12.1.1 Ingenuity
9.3.12.1.2 CLC Bio
9.3.12.2 Financial Performance
9.3.12.3 Financial Performance
9.3.12.4 Product Benchmarking
9.3.12.5 Strategic Initiatives
9.3.13 BGI
9.3.13.1 Company Overview
9.3.13.1.1 Complete Genomics Incorporated
9.3.13.2 Financial Performance
9.3.13.3 Product Benchmarking
9.3.13.4 Strategic Initiatives
9.3.14 Perkin Elmer, Inc.
9.3.14.1 Company Overview
9.3.14.2 Financial Performance
9.3.14.3 Product Benchmarking
9.3.14.4 Strategic Initiatives
9.3.15 Pacific Biosciences of California, Inc
9.3.15.1 Company Overview
9.3.15.2 Financial Performance
9.3.15.3 Product Benchmarking
9.3.15.4 Strategic Initiatives
9.3.16 Partek, Inc.
9.3.16.1 Company Overview
9.3.16.2 Financial Performance
9.3.16.3 Product Benchmarking
9.3.16.4 Strategic Initiatives
9.3.17 Bio-Rad Laboratories, Inc.
9.3.17.1 Company Overview
9.3.17.2 GnuBIO
9.3.17.3 Financial Performance
9.3.17.4 Product Benchmarking
9.3.17.5 Strategic Initiatives
9.3.18 Myriad Genetics
9.3.18.1 Company Overview
9.3.18.2 Financial Performance
9.3.18.3 Product Benchmarking
9.3.18.4 Strategic Initiatives
9.3.19 Hologic, Inc. (Gen-Probe Incorporated)
9.3.19.1 Company Overview
9.3.19.2 Financial Performance
9.3.19.3 Product Benchmarking
9.3.19.4 Strategic Initiatives

List of Tables

Table 1 Country share estimation
Table 2 Healthcare expenditure levels, 2012
Table 3 Global cancer incidences, 2012
Table 4 North America cancer incidences in 2012
Table 5 Europe cancer incidences, 2012
Table 6 Asia cancer incidences, 2012
Table 7 Africa cancer incidences, 2012
Table 8 Australia and New Zealand cancer incidences in 2012
Table 9 Major Sequencing Platforms Compared - Specifications
Table 10 Base pairs sequenced using WGS, WES, and targeted sequencing &resequencing
Table 11 Clonal amplification products in the market
Table 12 North America next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 13 North America NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 14 North America NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 15 North America next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 16 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 17 North America next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 18 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 19 North America NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 20 North America next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 21 U.S. next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 22 U.S. NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 23 U.S. NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 24 U.S. next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 25 U.S. targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 26 U.S. next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 27 U.S. NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 28 U.S. NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 29 U.S. next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 30 Canada next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 31 Canada NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 32 Canada NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 33 Canada next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 34 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 35 Canada next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 36 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 37 Canada NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 38 Canada next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 39 Europe next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 40 Europe NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 41 Europe NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 42 Europe next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 43 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 44 Europe next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 45 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 46 Europe NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 47 Europe next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 48 Germany next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 49 Germany NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 50 Germany NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 51 Germany next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 52 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 53 Germany next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 54 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 55 Germany NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 56 Germany next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 57 UK next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 58 UK NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 59 UK NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 60 UK next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 61 UK targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 62 UK next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 63 UK NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 64 UK NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 65 UK next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 66 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 67 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 68 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 69 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 70 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 71 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 72 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 73 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 74 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 75 Japan next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 76 Japan NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 77 Japan NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 78 Japan next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 79 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 80 Japan next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 81 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 82 Japan NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 83 Japan next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 84 China next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 85 China NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 86 China NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 87 China next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 88 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 89 China next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 90 China NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 91 China NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 92 China next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 93 Latin America next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 94 Latin America NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 95 Latin America NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 96 Latin America next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 97 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 98 Latin America next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 99 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 100 Latin America NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 101 Latin America next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 102 Brazil next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 103 Brazil NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 104 Brazil NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 105 Brazil next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 106 Brazil targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 107 Brazil next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 108 Brazil NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 109 Brazil NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 110 Brazil next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 111 MEA next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 112 MEA NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 113 MEA NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 114 MEA next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 115 MEA targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 116 MEA next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 117 MEA NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 118 MEA NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 119 MEA next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 120 South Africa next generation sequencing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 121 South Africa NGS clinical investigation market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 122 South Africa NGS reproductive health market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 123 South Africa next generation sequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 124 South Africa targeted sequencing/resequencing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
Table 125 South Africa next generation sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 126 South Africa NGS pre-sequencing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 127 South Africa NGS data analysis market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
Table 128 South Africa next generation sequencing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)

List of Figures

Figure 1 Market summary
Figure 2 Market trends & outlook
Figure 3 Market segmentation & scope
Figure 4 Market driver relevance analysis (Current & future impact)
Figure 5 Cost per raw megabase (Mb) of DNA sequence (USD)
Figure 6 Cost per genome
Figure 7 Expected rise in expenditure for cancer treatment (USD Billion)
Figure 8 Market restraint relevance analysis (Current & future impact)
Figure 9 Percentage of NGS sequencing reimbursement from payers
Figure 10 Bottlenecks associated with the NGS implementation
Figure 11 Penetration & growth prospect mapping for applications, 2015
Figure 12 Penetration & growth prospect mapping for prominent industry players, 2015
Figure 13 Major Sequencing Platforms Compared - Applications
Figure 14 NGS platform penetration mapping, 2015
Figure 15 Next generation sequencing company market share analysis, 2015
Figure 16 Payer perspectives for developing coverage policy for Next Generation Tumour Sequencing Panels (NGTS)
Figure 17 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 18 Porter’s Five Forces Analysis
Figure 19 Next generation sequencing market application outlook key takeaways
Figure 20 Next generation sequencing market: Application movement analysis
Figure 21 Global oncology market, 2014 - 2025 (USD Million)
Figure 22 Global clinical investigation market, 2014 - 2025 (USD Million)
Figure 23 Global infectious diseases market, 2014 - 2025 (USD Million)
Figure 24 Global inherited diseases market, 2014 - 2025 (USD Million)
Figure 25 Global idiopathic diseases market, 2014 - 2025 (USD Million)
Figure 26 Global non-communicable/other diseases market, 2014 - 2025 (USD Million)
Figure 27 Global reproductive health market, 2014 - 2025 (USD Million)
Figure 28 Global NIPT market, 2014 - 2025 (USD Million)
Figure 29 Global PGT market, 2014 - 2025 (USD Million)
Figure 30 Global new-born/genetic screening market, 2014 - 2025 (USD Million)
Figure 31 Global HLA typing/immune system monitoring market, 2014 - 2025 (USD Million)
Figure 32 Global metagenomics, epidemiology & drug development market, 2014 - 2025 (USD Million)
Figure 33 Global agrigenomics & forensics market, 2014 - 2025 (USD Million)
Figure 34 Global consumer genomics market, 2014 - 2025 (USD Million)
Figure 35 Next generation sequencing ma
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Illumina, Inc.
  • Roche Sequencing (45Life Sciences)
  • Agilent Technologies
  • PierianDx
  • Tute Genomics
  • Knome Inc.
  • Genomatix GmbH
  • GATC Biotech Ag
  • Oxford Nanopore Technologies
  • Macrogen Inc.
  • Thermo Fisher Scientific, Inc.
  • Life Technologies Corp.
  • DNASTAR Inc.
  • Biomatters Ltd.
  • Qiagen NV
  • Ingenuity
  • CLC Bio
  • BGI
  • Complete Genomics Incorporated
  • Perkin Elmer, Inc.
  • Pacific Biosciences of California, Inc
  • Partek, Inc.
  • Bio-Rad Laboratories, Inc.
  • GnuBIO
  • Myriad Genetics
  • Hologic, Inc. (Gen-Probe Incorporated)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll